CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation - PubMed (original) (raw)
CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation
K F Byth et al. J Exp Med. 1996.
Abstract
The CD45 transmembrane glycoprotein has been shown to be a protein phosphotyrosine phosphatase and to be important in signal transduction in T and B lymphocytes. We have employed gene targeting to create a strain of transgenic mice that completely lacks expression of all isoforms of CD45. The spleens from CD45-null mice contain approximately twice the number of B cells and one fifth the number of T cells found in normal controls. The increase in B cell numbers is due to the specific expansion of two B cell subpopulations that express high levels of immunoglobulin (IgM) staining. T cell development is significantly inhibited in CD45-null animals at two distinct stages. The efficiency of the development of CD4-CD8- thymocytes into CD4+ CD8+ thymocytes is reduced by twofold, subsequently the frequency of successful maturation of the double positive population into mature, single positive thymocytes is reduced by a further four- to fivefold. In addition, we demonstrate that CD45-null thymocytes are severely impaired in their apoptotic response to cross-linking signals via T cell receptor (TCR) in fetal thymic organ culture. In contrast, apoptosis can be induced normally in CD45-null thymocytes by non-TCR-mediated signals. Since both positive and negative selection require signals through the TCR complex, these findings suggest that CD45 is an important regulator of signal transduction via the TCR complex at multiple stages of T cell development. CD45 is absolutely required for the transmission of mitogenic signals via IgM and IgD. By contrast, CD45-null B cells proliferate as well as wild-type cells to CD40-mediated signals. The proliferation of B cells in response to CD38 cross-linking is significantly reduced but not abolished by the CD45-null mutation. We conclude that CD45 is not required at any stage during the generation of mature peripheral B cells, however its loss reveals a previously unrecognized role for CD45 in the regulation of certain subpopulations of B cells.
Similar articles
- Thymic selection generates T cells expressing self-reactive TCRs in the absence of CD45.
Trop S, Charron J, Arguin C, Lesage S, Hugo P. Trop S, et al. J Immunol. 2000 Sep 15;165(6):3073-9. doi: 10.4049/jimmunol.165.6.3073. J Immunol. 2000. PMID: 10975818 - CD45 enhances positive selection and is expressed at a high level in large, cycling, positively selected CD4+CD8+ thymocytes.
Ong CJ, Dutz JP, Chui D, Teh HS, Marth JD. Ong CJ, et al. Immunology. 1997 May;91(1):95-103. doi: 10.1046/j.1365-2567.1997.00216.x. Immunology. 1997. PMID: 9203971 Free PMC article. - Cross-talk between the T cell antigen receptor and the glucocorticoid receptor regulates thymocyte development.
Ashwell JD, King LB, Vacchio MS. Ashwell JD, et al. Stem Cells. 1996 Sep;14(5):490-500. doi: 10.1002/stem.140490. Stem Cells. 1996. PMID: 8888490 Review. - Fidelity and infidelity in commitment to B-lymphocyte lineage development.
Rolink AG, Schaniel C, Busslinger M, Nutt SL, Melchers F. Rolink AG, et al. Immunol Rev. 2000 Jun;175:104-11. Immunol Rev. 2000. PMID: 10933595 Review.
Cited by
- Inhibition of B cell receptor signaling induced by the human adenovirus species D E3/49K protein.
Hildenbrand A, Cramer P, Bertolotti M, Kaiser NS, Kläsener K, Nickel CM, Reth M, Heim A, Hengel H, Burgert HG, Ruzsics Z. Hildenbrand A, et al. Front Immunol. 2024 Jul 30;15:1432226. doi: 10.3389/fimmu.2024.1432226. eCollection 2024. Front Immunol. 2024. PMID: 39139562 Free PMC article. - Mechanical control of antigen detection and discrimination by T and B cell receptors.
Rogers J, Bajur AT, Salaita K, Spillane KM. Rogers J, et al. Biophys J. 2024 Aug 6;123(15):2234-2255. doi: 10.1016/j.bpj.2024.05.020. Epub 2024 May 23. Biophys J. 2024. PMID: 38794795 Free PMC article. Review. - Protein Tyrosine Phosphatase CD45 As an Immunity Regulator and a Potential Effector of CAR-T therapy.
Volkov DV, Stepanova VM, Rubtsov YP, Stepanov AV, Gabibov AG. Volkov DV, et al. Acta Naturae. 2023 Jul-Sep;15(3):17-26. doi: 10.32607/actanaturae.25438. Acta Naturae. 2023. PMID: 37908772 Free PMC article. - CD45 limits early Natural Killer cell development.
Meza Guzman LG, Hyland CD, Bidgood GM, Leong E, Shen Z, Goh W, Rautela J, Vince JE, Nicholson SE, Huntington ND. Meza Guzman LG, et al. Immunol Cell Biol. 2024 Jan;102(1):58-70. doi: 10.1111/imcb.12701. Epub 2023 Oct 19. Immunol Cell Biol. 2024. PMID: 37855066 Free PMC article. - CD45 alleviates airway inflammation and lung fibrosis by limiting expansion and activation of ILC2s.
Cui G, Shimba A, Jin J, Hojo N, Asahi T, Abe S, Ejima A, Okada S, Ohira K, Kato R, Tani-Ichi S, Yamada R, Ebihara T, Shiroguchi K, Ikuta K. Cui G, et al. Proc Natl Acad Sci U S A. 2023 Sep 5;120(36):e2215941120. doi: 10.1073/pnas.2215941120. Epub 2023 Aug 28. Proc Natl Acad Sci U S A. 2023. PMID: 37639581 Free PMC article.
References
- Annu Rev Immunol. 1989;7:339-69 - PubMed
- Annu Rev Immunol. 1995;13:93-126 - PubMed
- Proc Natl Acad Sci U S A. 1989 Nov;86(22):8959-63 - PubMed
- Proc Natl Acad Sci U S A. 1990 May;87(9):3435-9 - PubMed
- Nature. 1990 Jul 5;346(6279):66-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous